The use of growth factors, gene therapy and tissue engineering to improve meniscal healing

Channarong Kasemkijwattana, Jacques Menetrey, Hideyuki Goto, Christopher Niyibizi, Freddie H. Fu, Johnny Huard

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The meniscus plays important roles in the knee joint, including load transmission at the tibiofemoral articulation, shock absorption, lubrication, and stabilization of the knee joint, though its healing capacity remains limited. Meniscal healing requires the proliferation of meniscal fibrochondrocytes from either an intrinsic source at the site of injury or an extrinsic source from the blood supply or synovium. We have characterized the effects of various doses of nine growth factors on the meniscal fibrochondrocyte proliferation and collagen and non-collagen synthesis, and identified epidermal growth factor (EGF), transforming growth factor alpha (TGFα), basic fibroblast growth factor (bFGF) and platelet derived growth factor AB (PDGF-AB) as candidate molecules to improve meniscal healing. The direct administration of the human recombinant growth factor protein is likely to be limited by the short biological half-life of these proteins and the rapid clearance of the injected proteins. We have therefore evaluated the feasibility of gene therapy and tissue engineering to deliver marker genes into the meniscus and found that direct and myoblast mediated ex vivo gene transfer can be used to deliver high levels and persistent expression of these growth factors into the injured meniscus. This study will help in the development of strategies to improve meniscal healing using new innovative technologies such as gene therapy approaches.

Original languageEnglish (US)
Pages (from-to)19-28
Number of pages10
JournalMaterials Science and Engineering C
Volume13
Issue number1-2
DOIs
StatePublished - Sep 1 2000

Fingerprint

gene therapy
Gene therapy
tissue engineering
healing
Tissue engineering
Intercellular Signaling Peptides and Proteins
engineering
Gene transfer
Transforming Growth Factor alpha
Proteins
Fibroblast Growth Factor 2
Epidermal Growth Factor
Lubrication
proteins
genes
Blood
Collagen
Stabilization
Genes
Molecules

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Kasemkijwattana, Channarong ; Menetrey, Jacques ; Goto, Hideyuki ; Niyibizi, Christopher ; Fu, Freddie H. ; Huard, Johnny. / The use of growth factors, gene therapy and tissue engineering to improve meniscal healing. In: Materials Science and Engineering C. 2000 ; Vol. 13, No. 1-2. pp. 19-28.
@article{156d55e06e934b628956f6fdc8da6b6b,
title = "The use of growth factors, gene therapy and tissue engineering to improve meniscal healing",
abstract = "The meniscus plays important roles in the knee joint, including load transmission at the tibiofemoral articulation, shock absorption, lubrication, and stabilization of the knee joint, though its healing capacity remains limited. Meniscal healing requires the proliferation of meniscal fibrochondrocytes from either an intrinsic source at the site of injury or an extrinsic source from the blood supply or synovium. We have characterized the effects of various doses of nine growth factors on the meniscal fibrochondrocyte proliferation and collagen and non-collagen synthesis, and identified epidermal growth factor (EGF), transforming growth factor alpha (TGFα), basic fibroblast growth factor (bFGF) and platelet derived growth factor AB (PDGF-AB) as candidate molecules to improve meniscal healing. The direct administration of the human recombinant growth factor protein is likely to be limited by the short biological half-life of these proteins and the rapid clearance of the injected proteins. We have therefore evaluated the feasibility of gene therapy and tissue engineering to deliver marker genes into the meniscus and found that direct and myoblast mediated ex vivo gene transfer can be used to deliver high levels and persistent expression of these growth factors into the injured meniscus. This study will help in the development of strategies to improve meniscal healing using new innovative technologies such as gene therapy approaches.",
author = "Channarong Kasemkijwattana and Jacques Menetrey and Hideyuki Goto and Christopher Niyibizi and Fu, {Freddie H.} and Johnny Huard",
year = "2000",
month = "9",
day = "1",
doi = "10.1016/S0928-4931(00)00172-7",
language = "English (US)",
volume = "13",
pages = "19--28",
journal = "Materials Science and Engineering C",
issn = "0928-4931",
publisher = "Elsevier BV",
number = "1-2",

}

The use of growth factors, gene therapy and tissue engineering to improve meniscal healing. / Kasemkijwattana, Channarong; Menetrey, Jacques; Goto, Hideyuki; Niyibizi, Christopher; Fu, Freddie H.; Huard, Johnny.

In: Materials Science and Engineering C, Vol. 13, No. 1-2, 01.09.2000, p. 19-28.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The use of growth factors, gene therapy and tissue engineering to improve meniscal healing

AU - Kasemkijwattana, Channarong

AU - Menetrey, Jacques

AU - Goto, Hideyuki

AU - Niyibizi, Christopher

AU - Fu, Freddie H.

AU - Huard, Johnny

PY - 2000/9/1

Y1 - 2000/9/1

N2 - The meniscus plays important roles in the knee joint, including load transmission at the tibiofemoral articulation, shock absorption, lubrication, and stabilization of the knee joint, though its healing capacity remains limited. Meniscal healing requires the proliferation of meniscal fibrochondrocytes from either an intrinsic source at the site of injury or an extrinsic source from the blood supply or synovium. We have characterized the effects of various doses of nine growth factors on the meniscal fibrochondrocyte proliferation and collagen and non-collagen synthesis, and identified epidermal growth factor (EGF), transforming growth factor alpha (TGFα), basic fibroblast growth factor (bFGF) and platelet derived growth factor AB (PDGF-AB) as candidate molecules to improve meniscal healing. The direct administration of the human recombinant growth factor protein is likely to be limited by the short biological half-life of these proteins and the rapid clearance of the injected proteins. We have therefore evaluated the feasibility of gene therapy and tissue engineering to deliver marker genes into the meniscus and found that direct and myoblast mediated ex vivo gene transfer can be used to deliver high levels and persistent expression of these growth factors into the injured meniscus. This study will help in the development of strategies to improve meniscal healing using new innovative technologies such as gene therapy approaches.

AB - The meniscus plays important roles in the knee joint, including load transmission at the tibiofemoral articulation, shock absorption, lubrication, and stabilization of the knee joint, though its healing capacity remains limited. Meniscal healing requires the proliferation of meniscal fibrochondrocytes from either an intrinsic source at the site of injury or an extrinsic source from the blood supply or synovium. We have characterized the effects of various doses of nine growth factors on the meniscal fibrochondrocyte proliferation and collagen and non-collagen synthesis, and identified epidermal growth factor (EGF), transforming growth factor alpha (TGFα), basic fibroblast growth factor (bFGF) and platelet derived growth factor AB (PDGF-AB) as candidate molecules to improve meniscal healing. The direct administration of the human recombinant growth factor protein is likely to be limited by the short biological half-life of these proteins and the rapid clearance of the injected proteins. We have therefore evaluated the feasibility of gene therapy and tissue engineering to deliver marker genes into the meniscus and found that direct and myoblast mediated ex vivo gene transfer can be used to deliver high levels and persistent expression of these growth factors into the injured meniscus. This study will help in the development of strategies to improve meniscal healing using new innovative technologies such as gene therapy approaches.

UR - http://www.scopus.com/inward/record.url?scp=0034272847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034272847&partnerID=8YFLogxK

U2 - 10.1016/S0928-4931(00)00172-7

DO - 10.1016/S0928-4931(00)00172-7

M3 - Article

AN - SCOPUS:0034272847

VL - 13

SP - 19

EP - 28

JO - Materials Science and Engineering C

JF - Materials Science and Engineering C

SN - 0928-4931

IS - 1-2

ER -